Don’t invest unless you are prepared to lose all the money you invest. These are high-risk investments & you are unlikely to be protected if something goes wrong. Take 2 minutes to learn more.

EIS Fund: Case Studies

Below are a few examples of investments that the
Oxford Innovation EIS Growth Fund has made since launching.

Wayland Additives Logo

Wayland Additive

Enabling high value, mature technology transfer from the semiconductor industry to the additive manufacturing industry with its effective and accessible electron beam technology.

Wayland has built significant commercial momentum with three of its Calibur3 machines already shipped and a good sales pipeline. The company has seen significant valuation growth.

Investment Date:

November 2021

Since Investment:

They’ve proven the technology, sold commercially into several clients and have seen a valuation increase of over 5x,
Oxford Medical Products Logo

Oxford Medical Products

Oxford Medical Products have developed Sirona, a disruptive solution to the obesity crisis. Obesity is a pandemic with almost one third of adults overweight or obese, representing a global market of $160 billion. Sirona is a long-acting hydrogel pill that acts like a gastric balloon. It expands & stays in the stomach for several weeks causing a sensation of satiety, suppressing the taker’s appetite, before breaking down and passing naturally.

Investment Date:

February 2022

Since Investment:

The company has successfully completed human clinical trials and is planning a Series A Investment round in 2025.

If you are interested in investing in the current Oxford Innovation EIS Growth Fund, you can find out more on the Fund page.

Companies interested in receiving investment from the Oxford Innovation EIS Growth Fund should complete the Company Registration Form.